Guest User 5/5/16 Guest User 5/5/16

OBIO Hosts Annual Celebration of the Health Sciences Industry in Canada

Toronto, Ontario – May 5, 2016: Ontario Bioscience Innovation Organization (OBIO®) welcomed a prestigious group of investors, companies, MPPs and industry supporters to an intimate dinner on May 3 2016 in celebration of Canada’s health science industry. The event was supported by Torys LLP and by Bloom Burton & Co.

Donald Cudmore 4/29/16 Donald Cudmore 4/29/16

OBIO Launches Report on Building Canada’s Health Science Industry of the Future

Toronto, Ontario – April 29, 2016: Ontario Bioscience Innovation Organization (OBIO®) today released its report “How Canada Should be Engaging in a $9 Trillion Dollar Health Economy”. The report is the output of interviews and surveys of 125 CEOs of Canada’s health science companies looking at the future of the global industry and opportunities for Ontario and Canada.

Guest User 4/19/16 Guest User 4/19/16

OBIO Welcomes 12 New Bioscience Companies into the OBIO CAAP Program

Toronto, Ontario - April 19, 2016: The Ontario Bioscience Innovation Organization (OBIO®) kicked off its 2016 Capital Access Advisory Program (CAAP®) on April 13, hosted at sponsor Norton Rose Fulbright, Toronto.

Guest User 4/11/16 Guest User 4/11/16

OBIO brings Innovation in Action to Queen’s Park

Toronto, Ontario – April 11, 2016: Ontario Bioscience Innovation Organization (OBIO®) hosted its annual Queen’s Park Advocacy Day on April 5, attracting an impressive 150 attendees including 50 elected officials.

Guest User 2/12/16 Guest User 2/12/16

OBIO applauds federal funding for Natural Products Canada

February 12, 2016 – Toronto Ontario. Today, the Ontario Bioscience Innovation Organization welcomes the creation of Natural Products Canada Inc. (NPC), the nation’s newest Centre of Excellence for Commercialization and Research. Press Release. Click here for the press release.

Guest User 1/19/16 Guest User 1/19/16

OBIO Announces Pre-Capital Access Advisory Program for 2016

Toronto, Ontario, January 19, 2016 – Ontario Bioscience Innovation Organization (OBIO®) today announced the 2016 Pre-Capital Access Advisory Program (Pre-CAAP), a program in support of Ontario’s early stage bioscience companies. With access to capital as the number one challenge for bioscience start-ups in Ontario, Pre-CAAP combined with OBIO’s distinctive Capital Access Advisory Program (CAAP®) provides companies with key knowledge and insights to position them for financing and commercial success.

Guest User 12/3/15 Guest User 12/3/15

OBIO® MPP Health Science Caucus Launches Three Party Effort to Advance Industry

Toronto, Ontario, December 3, 2015 – OBIO announced today that MPPs from the three major parties have come together to work on policy initiatives to strengthen Ontario’s Health Science industry.

Guest User 11/4/15 Guest User 11/4/15

Ontario Bioscience Innovation Organization Announces Election of Shelley Boyd, Jeremy Bridge-Cook, Michael Cloutier and Cathy Szabo to its Board of Directors

Toronto, Ontario, November 4, 2015 – Ontario Bioscience Innovation Organization (“OBIO®”), a non-profit organization that is Ontario’s leading advocate for the life science sector, announces the election of four new members to its Board of Directors: Shelley Boyd, Jeremy Bridge-Cook, Michael Cloutier and Cathy Szabo.

Guest User 11/4/15 Guest User 11/4/15

Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2016 Capital Access Advisory Program

Toronto, Ontario, November 3, 2015 – Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization that is Ontario’s leading advocate for the life sciences sector, is pleased to announce a call for applications for the 2016 OBIO Capital Access Advisory Program (CAAP®).

Guest User 9/24/15 Guest User 9/24/15

Ontario Bioscience Innovation Organization Congratulates Ontario on the Appointment of Chief Health Innovation Strategist

Today, Ontario Bioscience Innovation Organization (OBIO®) released a statement congratulating the Government of Ontario on the appointment of William Charnetski as Ontario’s first Chief Health Innovation Strategist.

“OBIO congratulates Mr. Charnetski on his appointment to this pivotal role,” said Gail Garland, Chief Executive Officer of OBIO. “We look forward to supporting his efforts to catalyze adoption of innovative health technologies which strengthen the province’s capacity to deliver cost-effective, outcome-focused care for patients.”

obio 9/21/15 obio 9/21/15

OBIO Congratulates and Welcomes Johnson & Johnson Innovation, JLABS to the Ontario Bioscience Ecosystem

Toronto, Ontario, September 21, 2015 – The Ontario Bioscience Innovation Organization (OBIO®) is pleased to recognise Johnson & Johnson Innovation’s major contribution to Ontario’s human health bioscience ecosystem through the choice of Toronto as the first ex-US Johnson & Johnson Innovation, JLABS site. The JLABS incubator model is the highly successful creation of Johnson & Johnson Innovation and has been brought to Canada with the help of Janssen Inc. Known as JLABS @ Toronto, the site will join its fellow JLABS sites in San Diego, San Francisco, Boston and Houston.

obio 8/10/15 obio 8/10/15

Pre-Capital Access Advisory Program (Pre-CAAP)

OBIO Launches Pre-Capital Access Advisory Program (Pre-CAAP) – Builds on Successful Capital Access Advisory Program (CAAP™) Improving financing success of Ontario bioscience companies Toronto, Ontario, August 10, 2015 – Ontario Bioscience Innovation Organization (OBIO®) today announced the launch of the inaugural round of Pre-CAAP, a program in support of Ontario bioscience companies that aim to raise...

obio 5/23/15 obio 5/23/15

OBIO CAAP Program Receives FedDev Ontario Funding

Toronto, Ontario, May 22, 2015 – Ontario Bioscience Innovation Organization (OBIO®) today announced they have received an investment of up to $3.894 million from the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) for OBIO®’s Capital Access Advisory Program (CAAP™).

“It is tremendous to see this practical support for commercializing health sciences and for building our human health bioscience industry,” said Gail Garland, President and CEO, OBIO®. “We are deeply grateful for this opportunity to expand our programming and help even more growing companies.”

obio 2/9/15 obio 2/9/15

Ontario Bioscience Innovation Organization Presents to Provincial Standing Committee on Finance and Economic Affairs

Toronto, Ontario, January 29, 2015 – The Ontario Bioscience Innovation Organization (“OBIO®”), Ontario’s leading advocate for the health science industry, is pleased to announce that OBIO was invited to present today to the Provincial Standing Committee on Finance and Economic Affairs.

obio 1/14/15 obio 1/14/15

Ontario Bioscience Innovation Organization Announces Election of Cynthia Goh, Ian Smith and Mark Steedman to its Board of Directors

Ontario Bioscience Innovation Organization (“OBIO®”), a non-profit organization that is Ontario’s leading advocate for the life science sector, announces the election of three new members to its Board of Directors: Cynthia Goh, Ian Smith and Mark Steedman.